首页 正文

Clinical and research priorities for combined modality therapy in stage III NSCLC

{{output}}
Stage III NSCLC comprises of a heterogeneous group of patients with regard to stage, extent of disease and prognosis. Disease presentation can often be complex in clinical practice, and the challenges are not well-defined in clinical trials or practice guideli... ...